London, United Kingdom

Sanjay Kumar Kakkar

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sanjay Kumar Kakkar: Innovator in Pharmaceutical Formulations

Introduction

Sanjay Kumar Kakkar is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative patents. With a total of 2 patents, Kakkar's work focuses on the development of boronic acid salts and their applications in drug formulations.

Latest Patents

Kakkar's latest patents include "Boronic acid salts useful in parenteral formulations" and "Multivalent metal salts of boronic acids." The first patent discusses salts of a peptide boronic acid drug, such as Cbz-(R)-Phe-(S)-Pro-(R)-Mpg-B(OH). The counter-ion to the boronate may be an alkali metal or derived from a strongly basic organic nitrogen-containing compound. The second patent addresses salts of a pharmaceutically acceptable divalent metal and an organoboronic acid drug, with examples including calcium, magnesium, and zinc. These organoboronic acid drugs may serve as boropeptide protease inhibitors and can be formulated in oral dosage forms.

Career Highlights

Sanjay Kumar Kakkar is currently associated with Trigen GmbH, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficacy and safety of pharmaceutical products.

Collaborations

Kakkar collaborates with esteemed colleagues, including John Joseph Deadman and Mark Dolman, to further his research initiatives and drive innovation in the pharmaceutical industry.

Conclusion

Sanjay Kumar Kakkar's contributions to the field of pharmaceutical formulations through his innovative patents highlight his expertise and commitment to advancing medical science. His work continues to impact the development of effective drug therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…